lamina, extend to the cell periphery and immunostain for peripherin. The depletion of peripherin with siRNA eliminates the filamentous immunostaining of sAPP. Conclusion: Our results indicate that a fraction of APP is cleaved by β-secretase in the soma and that the generated sAPP becomes associated with perinuclear peripherin neurofilaments. These findings link the metabolism of APP -which is dysregulated in AD -to the organization of neurofilaments -which is abnormal in ALS -and suggest a possible crosstalk/overlap between the molecular mechanisms of these diseases.
upper and lower motor neurons are progressively lost by poorly understood mechanisms that, among others, lead to the disruption of the neurofilament networks and -ultimately -denervation of neuromuscular junctions [3, 4] . A recent study proposed that APP actively contributes to the neuronal pathology in certain forms of ALS [5] . Here, we provide evidence that the proteolytic processing of APP, and intraneuronal localization of APP-derived fragments depend on intact peripherin-containing neurofilaments present in the soma. These results point to a possible crosstalk between the molecular machineries involved in the pathogenesis of AD and ALS.
Methods
In this study, we employed CAD neuronal cells [6] [7] [8] , a brainstem-derived, neuronal cell line that, similar to the motor neurons, expresses peripherin. CAD neuronal cells also express APP, which is processed by secretases to generate the characteristic proteolytic fragments that are relevant to AD: sAPPβ, CTFβ, Aβ and AICD [9] [10] [11] ( fig. 1 a) . Immunocytochemistry, immunoblotting and transfection with peripherin siRNA (Santa Cruz Biotechnology) plus green fluorescent protein (GFP; to visualize transfected cells) were carried out as described [12, 13] . The antibodies recognizing epitopes from the N-(22C11) or C-terminal region (AB5352) of APP were from Millipore. Previous work indicated that in CAD neuronal cells, the antibody 22C11 largely detects sAPP (N-terminal fragment of APP) rather than full-length APP [9] . The antiperipherin antibody was kindly provided by Dr. Robert Goldman (Northwestern University).
Results
Our previous studies with cultured neurons and mouse brain in situ have shown that a significant fraction of APP is proteolytically cleaved by secretases in the neuronal soma, leading to the generation of N-and C-terminal fragments (sAPP and CTF; fig. 1 a) that are targeted to distinct neuronal compartments [9] . Immunocytochemistry with antibodies that detect epitopes within the N-and C-terminal regions of APP showed largely nonoverlapping distributions, with the antibodies to N-but not C-terminal epitopes labeling a network of tubular structures surrounding the nucleus ( fig. 1 b) . These results indicate that in these conditions, the antibodies to N-terminal epitopes largely reveal sAPP, not full-length APP. The immunolabeling pattern of sAPP was reminiscent of the cytoskeletal neurofilament network, which is tightly associated with the nuclear envelope. With dual immunolabeling, we showed that the sAPP detected in the soma displays strong colocalization with peripherin ( fig. 2 ), a subunit of neurofilaments expressed in the adult neurons of the peripheral nervous system and the brainstem [14] . We note that colocalization of APP with cytoskeletal filaments that are not microtubules was previously detected in glial cells [15] .
To examine the link between the distribution of sAPP and that of neurofilaments, we tested whether the depletion of peripherin protein affects the distribution of sAPP. Although neurofilament proteins are long lived, CAD neuronal cells showed significantly diminished peripherin levels 4 days after transfection with peripherin siRNA ( fig. 3 ) . Cells with reduced peripherin levels, visualized by the cotransfected GFP, lacked perinuclear peripherin and no longer showed the filamentous, perinuclear distribution of sAPP evident in nontransfected cells ( fig. 3 ). This result indicates that the presence of neurofilaments is required for either the generation of sAPP from full-length APP, or for the localization of sAPP-containing membrane vesicles along neurofilaments. Thus, this work uncovers a functional interaction between APP and peripherin neurofilaments in CAD neuronal cells.
Conclusions
This study identifies the neurofilament protein, peripherin, as a potential regulator of APP metabolism and trafficking in neurons. One possibility is that the proteolytic processing of APP occurs in a compartment -endosomes, or part of the endoplasmic reticulum [16] -associated with the neurofilament cytoskeleton. Alternative- ly, the neurofilaments could play a role in the segregation of the sAPP from CTF, once they have been generated in a somatic compartment, by selectively anchoring, and concentrating, sAPP-containing vesicles in the perinuclear region. This region has been recently shown to be a site for accumulation of APP-derived polypeptides, with relevance to AD [17] . Interestingly, ALS-specific mutations in the peripherin gene [18, 19] lead to abnormal neurofilament organization [for a review, see ref . 20 ] . In principle, these cytoskeletal changes could cause abnormal processing -and thus altered function -of APP, a possibility supported by our results. We propose that this functional interaction between APP and peripherin neurofilaments may provide the basis for crosstalk between the molecular mechanisms of disease in AD and ALS. 
